Press releases
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Announces Upcoming Conference Presentations
- Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
- Dexcom Reports First Quarter 2022 Financial Results
- DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes
- Dexcom Publishes Annual Sustainability Report
- Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System, to Its Range of Scan-Free and Fingerprick†-Free Devices
- Dexcom Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 at 4:30 p.m. Eastern Time
- Dexcom Announces Four-for-One Forward Stock Split
- Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
More ▼
Key statistics
As of last trade, Dexcom Inc (DC4:BRN) traded at 432.97, 28.69% above the 52 week low of 336.44 set on Feb 24, 2022.
52-week range
Markit short selling activity
Open | 432.97 |
---|---|
High | 432.97 |
Low | 432.97 |
Bid | 420.97 |
Offer | 421.58 |
Previous close | 432.97 |
Average volume | -- |
---|---|
Shares outstanding | 98.13m |
Free float | 97.73m |
P/E (TTM) | 140.92 |
Market cap | 28.27bn USD |
EPS (TTM) | 2.04 USD |
Data delayed at least 15 minutes, as of Mar 23 2022.
More ▼